Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors
Ayesa Syenina, Cyril J Jagaraj, Siti A B Aman, Aishwarya Sridharan, Ashley L St John, Ayesa Syenina, Cyril J Jagaraj, Siti A B Aman, Aishwarya Sridharan, Ashley L St John
Abstract
Dengue virus (DENV) is the most significant human arboviral pathogen and causes ∼400 million infections in humans each year. In previous work, we observed that mast cells (MC) mediate vascular leakage during DENV infection in mice and that levels of MC activation are correlated with disease severity in human DENV patients (St John et al., 2013b). A major risk factor for developing severe dengue is secondary infection with a heterologous serotype. The dominant theory explaining increased severity during secondary DENV infection is that cross-reactive but non-neutralizing antibodies promote uptake of virus and allow enhanced replication. Here, we define another mechanism, dependent on FcγR-mediated enhanced degranulation responses by MCs. Antibody-dependent mast cell activation constitutes a novel mechanism to explain enhanced vascular leakage during secondary DENV infection.
Keywords: Fc receptor; antibodies; dengue virus; immunology; infectious disease; mast cell; microbiology; mouse; vascular leakage.
Conflict of interest statement
The authors declare that no competing interests exist.
Figures
References
- Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nature Reviews Immunology. 2010;10:440–452. doi: 10.1038/nri2782.
- Anderson KB, Gibbons RV, Cummings DA, Nisalak A, Green S, Libraty DH, Jarman RG, Srikiatkhachorn A, Mammen MP, Darunee B, Yoon IK, Endy TP. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. The Journal of Infectious Diseases. 2014;209:360–368. doi: 10.1093/infdis/jit436.
- Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. The Indian Journal of Medical Research. 2006;123:25–30.
- Daëron M, Bonnerot C, Latour S, Fridman WH. Murine recombinant Fc gamma RIII, but not Fc gamma RII, trigger serotonin release in rat basophilic leukemia cells. Journal of Immunology. 1992;149:1365–1373.
- Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745–748. doi: 10.1126/science.1185181.
- Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proceedings of the National Academy of Sciences of USA. 2007;104:9422–9427. doi: 10.1073/pnas.0703498104.
- Guilarde AO, Turchi MD, Siqueira JB, Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. The Journal of Infectious Diseases. 2008;197:817–824. doi: 10.1086/528805.
- Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476–481. doi: 10.1126/science.3277268.
- Halstead SB. Dengue. Lancet. 2007;370:1644–1652. doi: 10.1016/S0140-6736(07)61687-0.
- Halstead SB, Chow JS, Marchette NJ. Immunological enhancement of dengue virus replication. Nature. 1973;243:24–26.
- Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. The Yale Journal of Biology and Medicine. 1970;42:311–328.
- Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 1977a;265:739–741. doi: 10.1038/265739a0.
- Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. The Journal of Experimental Medicine. 1977b;146:201–217. doi: 10.1084/jem.146.1.201.
- Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daëron M, van de Winkel JG, Verbeek JS. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity. 1996;5:181–188. doi: 10.1016/S1074-7613(00)80494-X.
- Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. The American Journal of Tropical Medicine and Hygiene. 1982;31:830–836.
- Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P, Maniez-Montreuil M. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. The American Journal of Tropical Medicine and Hygiene. 1993;48:324–331.
- Jin C, Shelburne CP, Li G, Potts EN, Riebe KJ, Sempowski GD, Foster WM, Abraham SN. Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. The Journal of Clinical Investigation. 2011;121:941–955. doi: 10.1172/JCI43584.
- King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. Journal of Virology. 2000;74:7146–7150. doi: 10.1128/JVI.74.15.7146-7150.2000.
- Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. The American Journal of Tropical Medicine and Hygiene. 1988;38:411–419.
- Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. Journal of Medical Virology. 2003;70:91–98. doi: 10.1002/jmv.10358.
- Kunder CA, St John AL, Abraham SN. Mast cell modulation of the vascular and lymphatic endothelium. Blood. 2011;118:5383–5393. doi: 10.1182/blood-2011-07-358432.
- Kunder CA, St John AL, Li G, Leong KW, Berwin B, Staats HF, Abraham SN. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. The Journal of Experimental Medicine. 2009;206:2455–2467. doi: 10.1084/jem.20090805.
- Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A. Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Annals of the Academy of Medicine, Singapore. 2006;35:783–789.
- Malbec O, Daëron M. The mast cell IgG receptors and their roles in tissue inflammation. Immunological Reviews. 2007;217:206–221. doi: 10.1111/j.1600-065X.2007.00510.x.
- Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. Journal of immunology. 2000;164:4332–4339. doi: 10.4049/jimmunol.164.8.4332.
- Oshiba A, Hamelmann E, Takeda K, Bradley KL, Loader JE, Larsen GL, Gelfand EW. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. The Journal of Clinical Investigation. 1996;97:1398–1408. doi: 10.1172/JCI118560.
- Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nature Reviews Immunology. 2011;11:532–543. doi: 10.1038/nri3014.
- Sabin AB. Research on dengue during World War II. The American Journal of Tropical Medicine and Hygiene. 1952;1:30–50.
- Sanchez LF, Hotta H, Hotta S, Homma M. Degranulation and histamine release from murine mast cells sensitized with dengue virus-immune sera. Microbiology and Immunology. 1986;30:753–759. doi: 10.1111/j.1348-0421.1986.tb03002.x.
- Schulze IT, Schlesinger RW. Plaque assay of dengue and other group B arthropod-borne viruses under methyl cellulose overlay media. Virology. 1963;19:40–48. doi: 10.1016/0042-6822(63)90022-9.
- Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. Journal of Virology. 2006;80:10208–10217. doi: 10.1128/JVI.00062-06.
- Sithiprasasna R, Strickman D, Innis BL, Linthicum KJ. ELISA for detecting dengue and Japanese encephalitis viral antigen in mosquitoes. Annals of Tropical Medicine and Parasitology. 1994;88:397–404.
- St John AL. Influence of mast cells on dengue protective immunity and immune pathology. PLOS Pathogens. 2013;9:e1003783. doi: 10.1371/journal.ppat.1003783.
- St John AL, Abraham SN, Gubler DJ. Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nature Reviews Microbiology. 2013a;11:420–426. doi: 10.1038/nrmicro3030.
- St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife. 2013b;2:e00481. doi: 10.7554/eLife.00481.
- St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, Abraham SN. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proceedings of the National Academy of Sciences of USA. 2011;108:9190–9195. doi: 10.1073/pnas.1105079108.
- Sylvestre DL, Ravetch JV. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity. 1996;5:387–390. doi: 10.1016/S1074-7613(00)80264-2.
- Takizawa F, Adamczewski M, Kinet JP. Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as Fc gamma RII and Fc gamma RIII. The Journal of Experimental Medicine. 1992;176:469–475. doi: 10.1084/jem.176.2.469.
- Vaz NM, Ovary Z. Passive anaphylaxis in mice with gamma-G antibodies. 3. Release of histamine from mast cells by homologous antibodies. Journal of Immunology. 1968;100:1014–1019.
- Vaz NM, Prouvost-Danon A. Behaviour of mouse mast cells during anaphylaxis in vitro. Progress in Allergy. 1969;13:111–173.
- Wahala WM, Huang C, Butrapet S, White LJ, de Silva AM. Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera. Journal of Virology. 2012;86:4019–4023. doi: 10.1128/JVI.06871-11.
- World Health Organization . Dengue: guidelines for diagnosis, treatment, prevention and control - new edition. Geneva: World Health Organization; 2009.
- Yamanaka A, Kosugi S, Konishi E. Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. Journal of Virology. 2008;82:927–937. doi: 10.1128/JVI.00992-07.
Source: PubMed